Please use this identifier to cite or link to this item: https://hdl.handle.net/1/2576
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCoorey, Craig Peter-
dc.contributor.authorde Malmanche, Theo-
dc.contributor.authorChou, Angela-
dc.contributor.authorFeddersen, Martin-
dc.date.accessioned2024-04-23T23:51:44Z-
dc.date.available2024-04-23T23:51:44Z-
dc.date.issued2024-04-11-
dc.identifier.citationOnline ahead of printen
dc.identifier.urihttps://hdl.handle.net/1/2576-
dc.description.abstractHere we present a case of complement-mediated thrombotic microangiopathy (TMA) in a patient who has a background of Stage 5 chronic kidney disease secondary to Alport syndrome. We explain our approach to the diagnosis of TMA, especially the reliance on non-renal manifestations of TMA and the role of kidney biopsy given there was a background of advanced kidney impairment at baseline.en
dc.description.sponsorshipRenalen
dc.subjectKidney Diseaseen
dc.titleComplement-mediated thrombotic microangiopathy on a background of Alport syndrome: A case reporten
dc.typeJournal Articleen
dc.identifier.doi10.1111/nep.14305en
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/38604610en
dc.description.affiliatesCentral Coast Local Health Districten
dc.description.affiliatesGosford Hospitalen
dc.identifier.journaltitleNephrology (Carlton, Vic.)en
dc.type.contentTexten
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
Appears in Collections:Renal Medicine
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.